BCIwiki (bciwiki.com) — A clinical trial of a multimodal brain-computer interface (BCI) intelligent diagnosis and treatment system for early screening and non-invasive regulation of Alzheimer's disease has been registered at the Chinese Clinical Trial Registry (ChiCTR). The registration number is ChiCTR2600125240, registered on May 22, 2026, and recruitment has not yet begun. The trial information was made public via the WHO International Clinical Trials Registry Platform (ICTRP).
According to the registration record, the system is called a "multimodal BCI intelligent diagnosis and treatment system," but details such as trial design, sample size, and sponsor have not been disclosed in the entry and require verification against the original registration. Alzheimer's disease is a common neurodegenerative disorder, and early screening and intervention are important for slowing disease progression. The application of BCI technology in this area is still at an exploratory stage.